tiprankstipranks
Advertisement
Advertisement

PCRIVAN Stock Latest News

RIVANNA Highlights Accuro 3S Early Access and Data-Generation Strategy
Private CompaniesRIVANNA Highlights Accuro 3S Early Access and Data-Generation Strategy
18h ago
RIVAN
RIVANNA Highlights Early Access Expansion for Accuro 3S Anesthesia Platform
PremiumPrivate Companies
RIVANNA Highlights Early Access Expansion for Accuro 3S Anesthesia Platform
1d ago
RIVAN
RIVANNA Builds Momentum With AI-Guided Ultrasound Platforms and Expanding Clinical Evidence
PremiumPrivate Companies
RIVANNA Builds Momentum With AI-Guided Ultrasound Platforms and Expanding Clinical Evidence
1d ago
RIVAN
RIVANNA Highlights Accuro 3S Rollout and Early-Access Strategy at SOAP 2026
PremiumPrivate Companies
RIVANNA Highlights Accuro 3S Rollout and Early-Access Strategy at SOAP 2026
2d ago
RIVAN
RIVANNA Showcases AI-Guided Accuro 3S Platform and Expands Early-Access Program
PremiumPrivate Companies
RIVANNA Showcases AI-Guided Accuro 3S Platform and Expands Early-Access Program
3d ago
RIVAN
Clinical Study Highlights Scalability of RIVANNA Accuro XV Ultrasound Platform
PremiumPrivate CompaniesClinical Study Highlights Scalability of RIVANNA Accuro XV Ultrasound Platform
4d ago
RIVAN
Clinical Study Highlights Usability of RIVANNA’s Accuro XV in Emergency Imaging
Premium
Private Companies
Clinical Study Highlights Usability of RIVANNA’s Accuro XV in Emergency Imaging
4d ago
RIVAN
RIVANNA Study Shows Accuro XV Enables Non-Physicians to Capture Diagnostic-Quality MSK Images
Premium
Private Companies
RIVANNA Study Shows Accuro XV Enables Non-Physicians to Capture Diagnostic-Quality MSK Images
4d ago
RIVAN
RIVANNA Accelerates Accuro XV Clinical Program and Builds AI-Driven Anesthesia Strategy
PremiumPrivate Companies
RIVANNA Accelerates Accuro XV Clinical Program and Builds AI-Driven Anesthesia Strategy
8d ago
RIVAN
RIVANNA Expands Accuro XV Clinical Program and Targets Faster 510(k) Pathway
PremiumPrivate Companies
RIVANNA Expands Accuro XV Clinical Program and Targets Faster 510(k) Pathway
11d ago
RIVAN
RIVANNA Expands Accuro XV Clinical Program Across Major U.S. Academic Medical Centers
PremiumPrivate Companies
RIVANNA Expands Accuro XV Clinical Program Across Major U.S. Academic Medical Centers
11d ago
RIVAN
RIVANNA Fast-Tracks AI Fracture Detection With BARDA-Backed Multi-Site Study Expansion
PremiumPrivate Companies
RIVANNA Fast-Tracks AI Fracture Detection With BARDA-Backed Multi-Site Study Expansion
11d ago
RIVAN
RIVANNA Highlights AI-Enabled Trends in Neuraxial Anesthesia
PremiumPrivate CompaniesRIVANNA Highlights AI-Enabled Trends in Neuraxial Anesthesia
16d ago
RIVAN
RIVANNA Highlights Technology-Driven Trends in Neuraxial Anesthesia
Premium
Private Companies
RIVANNA Highlights Technology-Driven Trends in Neuraxial Anesthesia
16d ago
RIVAN
RIVANNA Highlights BARDA-Backed AI Ultrasound Progress and Accelerated 510(k) Pathway
Premium
Private Companies
RIVANNA Highlights BARDA-Backed AI Ultrasound Progress and Accelerated 510(k) Pathway
2M ago
RIVAN
RIVANNA Showcases Accuro XV AI Imaging Platform at AAOS 2026
PremiumPrivate Companies
RIVANNA Showcases Accuro XV AI Imaging Platform at AAOS 2026
2M ago
RIVAN
RIVANNA Showcases AI-Powered Accuro XV Imaging Platform at AAOS 2026
PremiumPrivate Companies
RIVANNA Showcases AI-Powered Accuro XV Imaging Platform at AAOS 2026
2M ago
RIVAN
RIVANNA Showcases AI Point-of-Care Imaging at Key 2026 Medtech Conferences
PremiumPrivate Companies
RIVANNA Showcases AI Point-of-Care Imaging at Key 2026 Medtech Conferences
2M ago
RIVAN
RIVANNA Targets Clinical, Executive, and Investor Audiences With 2026 Medtech Conference Push
PremiumPrivate Companies
RIVANNA Targets Clinical, Executive, and Investor Audiences With 2026 Medtech Conference Push
2M ago
RIVAN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >